Exploring the characteristics of patients with mesothelioma who chose active symptom control over chemotherapy as first-line treatment: a prospective, observational, single centre study
Abstract Background Mesothelioma is an aggressive thoracic tumour with a poor prognosis. The only treatment that extends survival is chemotherapy. However, in the UK, up to 50% of patients who are suitable for chemotherapy choose not to receive it, opting for active symptom control instead. The aim...
Main Authors: | Anna C. Bibby, Duneesha De Fonseka, Anna J. Morley, Emma Keenan, Alfredo Addeo, Sarah Smith, Anthony J. Edey, Nick A. Maskell |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2017-12-01
|
Series: | BMC Palliative Care |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12904-017-0255-3 |
Similar Items
-
Lymphocyte predominance in blood, pleural fluid, and tumour stroma; a prognostic marker in pleural mesothelioma
by: Duneesha De Fonseka, et al.
Published: (2022-04-01) -
Zoledronic acid in the management of mesothelioma - a feasibility study (Zol-A Trial): study protocol for a randomised controlled trial
by: Duneesha de Fonseka, et al.
Published: (2018-08-01) -
A prospective study to investigate the role of serial serum mesothelin in monitoring mesothelioma
by: Duneesha de Fonseka, et al.
Published: (2018-02-01) -
Ancillary Diagnostic Investigations in Malignant Pleural Mesothelioma
by: Alex Dipper, et al.
Published: (2021-06-01) -
Investigational approaches for mesothelioma
by: Veerle F Surmont, et al.
Published: (2011-08-01)